The mechanism: how semaglutide produces weight loss Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist
Ohtsuki M, Okubo Y, Komine M, Imafuku S, Day RM, Chen P, Petric R, Maroli A, Nemoto O (2017) Apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of Japanese patients with moderate to severe plaque psoriasis: efficacy, safety and tolerability results from a phase 2b randomized controlled trial
Peptide injections are bioactive amino acid chains administered subcutaneously or intradermally to stimulate specific cellular pathways
While no scientific studies have compared pharmaceutical drugs with supplements, a healthy diet including nutrient-dense foods and regular physical activity plays a vital role in weight management